156 related articles for article (PubMed ID: 27282741)
21. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
22. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.
Park JY; Jeong HJ; Kim YM; Park SJ; Rho MC; Park KH; Ryu YB; Lee WS
Bioorg Med Chem Lett; 2011 Sep; 21(18):5602-4. PubMed ID: 21824777
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
Gilleron P; Wlodarczyk N; Houssin R; Farce A; Laconde G; Goossens JF; Lemoine A; Pommery N; Hénichart JP; Millet R
Bioorg Med Chem Lett; 2007 Oct; 17(19):5465-71. PubMed ID: 17827015
[TBL] [Abstract][Full Text] [Related]
24. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.
Baciu-Atudosie L; Ghinet A; Farce A; Dubois J; Belei D; Bîcu E
Bioorg Med Chem Lett; 2012 Nov; 22(22):6896-902. PubMed ID: 23036952
[TBL] [Abstract][Full Text] [Related]
26. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
27. Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
Hofmann E; Webster J; Do T; Kline R; Snider L; Hauser Q; Higginbottom G; Campbell A; Ma L; Paula S
Bioorg Med Chem; 2016 Feb; 24(4):578-87. PubMed ID: 26762836
[TBL] [Abstract][Full Text] [Related]
28. Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Bolchi C; Pallavicini M; Bernini SK; Chiodini G; Corsini A; Ferri N; Fumagalli L; Straniero V; Valoti E
Bioorg Med Chem Lett; 2011 Sep; 21(18):5408-12. PubMed ID: 21802946
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
[TBL] [Abstract][Full Text] [Related]
30. Chalcones: As Potent α-amylase Enzyme Inhibitors; Synthesis, In Vitro, and In Silico Studies.
Ali M; Khan M; Zaman K; Wadood A; Iqbal M; Alam A; Shah S; Ashfaq Ur Rehman ; Yousaf M; Rafique R; Khan KM
Med Chem; 2021; 17(8):903-912. PubMed ID: 32525781
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure elucidation of five new conjugates of oleanolic acid derivatives and chalcones using 1D and 2D NMR spectroscopy.
Tang C; Zhu L; Li J; Qin R; Liu C; Chen Y; Yang G
Magn Reson Chem; 2012 Mar; 50(3):236-41. PubMed ID: 22383429
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of small libraries of triazolylmethoxy chalcones, flavanones and 2-aminopyrimidines as inhibitors of mycobacterial FAS-II and PknG.
Anand N; Singh P; Sharma A; Tiwari S; Singh V; Singh DK; Srivastava KK; Singh BN; Tripathi RP
Bioorg Med Chem; 2012 Sep; 20(17):5150-63. PubMed ID: 22854194
[TBL] [Abstract][Full Text] [Related]
33. An overview on natural farnesyltransferase inhibitors for efficient cancer therapy.
Dai X; Sun Y; Zhang T; Ming Y; Hongwei G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1027-1044. PubMed ID: 32308053
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
Xue Y; Tang J; Ma X; Li Q; Xie B; Hao Y; Jin H; Wang K; Zhang G; Zhang L; Zhang L
Eur J Med Chem; 2016 Jun; 115():94-108. PubMed ID: 26994846
[TBL] [Abstract][Full Text] [Related]
35. Discovery and preliminary structure-activity relationship studies on tecomaquinone I and tectol as novel farnesyltransferase and plasmodial inhibitors.
Cadelis MM; Bourguet-Kondracki ML; Dubois J; Valentin A; Barker D; Copp BR
Bioorg Med Chem; 2016 Jul; 24(14):3102-7. PubMed ID: 27240468
[TBL] [Abstract][Full Text] [Related]
36. Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors.
Radhakrishnan S; Shimmon R; Conn C; Baker A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4085-91. PubMed ID: 26318997
[TBL] [Abstract][Full Text] [Related]
37. On the discovery of new potent human farnesyltransferase inhibitors: emerging pyroglutamic derivatives.
Homerin G; Lipka E; Rigo B; Farce A; Dubois J; Ghinet A
Org Biomol Chem; 2017 Oct; 15(38):8110-8118. PubMed ID: 28905970
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
[TBL] [Abstract][Full Text] [Related]
39. Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.
Huang W; Zuo T; Luo X; Jin H; Liu Z; Yang Z; Yu X; Zhang L; Zhang L
Chem Biol Drug Des; 2013 Jun; 81(6):730-41. PubMed ID: 23405965
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors.
Huo PC; Guan XQ; Liu P; Song YQ; Sun MR; He RJ; Zou LW; Xue LJ; Shi JH; Zhang N; Liu ZG; Ge GB
Eur J Med Chem; 2021 Jan; 209():112856. PubMed ID: 33007602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]